Sort:
Basic Research Issue
Luteolin attenuates vascular smooth muscle cell senescence by regulating ferroptosis through SLC7A11/GPX4 signaling pathway
Chinese Journal of Multiple Organ Diseases in the Elderly 2026, 25(3): 215-221
Published: 28 March 2026
Abstract PDF (1.3 MB) Collect
Downloads:0
Objective

To investigate the molecular mechanism by which luteolin (Lut) alleviates vascular smooth muscle cells (VSMCs) senescence by regulating ferroptosis via the solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) signaling pathway, thereby providing novel insights for the prevention and treatment of vascular aging-related diseases.

Methods

Mouse vascular smooth muscle cells (MOVAS) were subjected and randomly divided into blank control group (Con group), Lut group (5 μ mol/L Lut for 24 h), doxorubicin group (DOX group, 1 μ mol/L DOX for 24 h), and combined treatment group (DOX+Lut group, pretreatment of 5 μ mol/L Lut for 24 h followed by DOX treatment). Cell senescence and viability were evaluated using senescence-associated β-galactosidase (SA-β-gal) staining and cell counting kit-8 (CCK-8) assay, respectively. The expression of senescence-related proteins (P53, P21, P16) and ferroptosis pathway proteins (SLC7A11, GPX4) was detected by Western blot. Reactive oxygen species (ROS) production was measured by flow cytometry. Lipid peroxidation and intracellular ferrous iron (Fe2+) levels were detected using lipid peroxidation fluorescent probes and FerroOrange fluorescent probe, respectively. Additionally, glutathione (GSH) and malondialdehyde (MDA) contents in cell lysates were measured. SLC7A11 inhibitor Erastin was used to intervene ferroptosis to observe the changes in senescence phenotypes. GraphPad Prism 10.0 software was employed for data analysis. Multiple-group comparison was performed using one-way ANOVA followed by Tukey's post hoc test, and intergroup comparison was applied using a two-tailed independent sample t test.

Results

Compared with the Con group, the DOX group exhibited significantly decreased cell viability (IC50=1.799 μmol/L) and an obviously increased proportion of SA-β-gal-positive senescent cells (approximately 63%, P<0.05), accompanied with upregulated senescence proteins (P53, P21, P16), elevated ROS and lipid peroxidation levels, marked accumulation of Fe2+, reduced GSH content, and notably downregulated expression of SLC7A11 and GPX4 proteins (P<0.05). The addition of Lut pretreatment remarkably improved the aforementioned indicators, such as the IC50 value increasing to 2.192 μmol/L, the proportion of senescent cells decreasing to approximately 38%, and restored protein levels of SLC7A11 and GPX4 when compared with the levels in the DOX group (P<0.05).

Conclusion

Lut effectively inhibits DOX-induced ferroptosis and alleviates VSMC senescence by activating the SLC7A11/GPX4 signaling pathway, providing a theoretical basis for the treatment of vascular aging-related diseases.

Open Access Original Article Issue
Dual‐modality imaging for identifying thrombosis via platelet GPⅡb/Ⅲa receptor targeted cyclic RGDfK microbubbles
iRADIOLOGY 2024, 2(3): 227-239
Published: 16 February 2024
Abstract PDF (2.1 MB) Collect
Downloads:442
Background

Acute thrombotic events play a major role in various cardiovascular diseases. Therefore, direct thrombus imaging can be proved beneficial for early diagnosis and prompt therapy of thrombosis. Our study investigated targeted dual‐modality cyclic arginine‐glycine‐aspartic micro bubbles (cRGD‐MBs) for direct imaging of thrombi by fluorescence and ultrasound.

Methods

cRGD‐MBs were prepared by mechanical vibration and chemical chelation methods.

Results

Coulter counter analysis demonstrated that the cRGD‐MBs were well dispersed, with diameters ranging from 1 to 3 μm. They emitted bright red fluorescence under an excitation wavelength of 660 nm. In vivo fluorescence and ultrasound imaging revealed that cRGD‐MBs accumulated at the site of thrombus in the carotid artery with significant fluorescence and ultrasonic signal.

Conclusions

This study showed that novel microbubble cRGD‐MBs were successfully synthesized, and that these could potentially be used as contrast agents for immediate diagnosis of acute thrombus in vivo.

Open Access Research Article Issue
Establishment of a diagnostic model of coronary heart disease in elderly patients with diabetes mellitus based on machine learning algorithms
Journal of Geriatric Cardiology 2022, 19(6): 445-455
Published: 28 June 2022
Abstract PDF (6.5 MB) Collect
Downloads:107
OBJECTIVE

To establish a prediction model of coronary heart disease (CHD) in elderly patients with diabetes mellitus (DM) based on machine learning (ML) algorithms.

METHODS

Based on the Medical Big Data Research Centre of Chinese PLA General Hospital in Beijing, China, we identified a cohort of elderly inpatients (≥ 60 years), including 10,533 patients with DM complicated with CHD and 12,634 patients with DM without CHD, from January 2008 to December 2017. We collected demographic characteristics and clinical data. After selecting the important features, we established five ML models, including extreme gradient boosting (XGBoost), random forest (RF), decision tree (DT), adaptive boosting (Adaboost) and logistic regression (LR). We compared the receiver operating characteristic curves, area under the curve (AUC) and other relevant parameters of different models and determined the optimal classification model. The model was then applied to 7447 elderly patients with DM admitted from January 2018 to December 2019 to further validate the performance of the model.

RESULTS

Fifteen features were selected and included in the ML model. The classification precision in the test set of the XGBoost, RF, DT, Adaboost and LR models was 0.778, 0.789, 0.753, 0.750 and 0.689, respectively; and the AUCs of the subjects were 0.851, 0.845, 0.823, 0.833 and 0.731, respectively. Applying the XGBoost model with optimal performance to a newly recruited dataset for validation, the diagnostic sensitivity, specificity, precision, and AUC were 0.792, 0.808, 0.748 and 0.880, respectively.

CONCLUSIONS

The XGBoost model established in the present study had certain predictive value for elderly patients with DM complicated with CHD.

Open Access Research Article Issue
Effects of sodium-glucose cotransporter 2 inhibitors on cardiovascular outcomes in elderly patients with comorbid coronary heart disease and diabetes mellitus
Journal of Geriatric Cardiology 2021, 18(6): 440-448
Published: 28 June 2021
Abstract PDF (7.3 MB) Collect
Downloads:105
OBJECTIVE

To investigate the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on cardiovascular outcomes in elderly Chinese patients with comorbid coronary heart disease (CHD) and type 2 diabetes mellitus (T2DM).

METHODS

A retrospective cohort study was conducted on 501 elderly inpatients (≥ 60 years) with comorbid CHD/T2DM in Department of Cardiovascular Medicine and Endocrinology, Chinese PLA General Hospital from January 2018 to December 2019. These patients were divided into two groups according to the administration of SGLT2i. All the demographic characteristics and clinical data were collected. Cardiovascular outcomes, including all-cause mortality, major adverse cardiovascular events (MACE), and hospitalization for heart failure (HHF), were followed up.

RESULTS

In the cohort, there were 167 patients in the SGLT2i group and 334 patients in the control group. In the efficacy analyses, the incidence of MACE was lower in the SGLT2i group than in the control group: 3.6% vs. 9.3% (P = 0.022). A lower risk of MACE was observed in the SGLT2i group [hazard ratio (HR) = 0.40, 95% CI: 0.17–0.95]. There was no significant difference in the incidence of all-cause mortality or HHF between the two groups. No significant difference of HR was observed for all-cause mortality (HR = 0.41, 95% CI: 0.12–1.41) or HHF (HR = 0.58, 95% CI: 0.12–2.81).

CONCLUSIONS

SGLT2i treatment exhibited benefits for elderly patients with comorbid CHD/T2DM with a lower risk for MACE.

Total 4